Research Points to Translational Path Toward Precision Immunotherapies for EGFR-Mutant NSCLC

Wu-Kong28 Data Support Sunvozertinib as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says

… as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says … Haleigh Behrman …

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …

A Shift in Focus: Real-World Data Reframe the Value of N1 Nodal Assessments in Resection

… lung cancer resection. Historically, much of the data and research have largely focused on examining N2 lymph nodes … extensive sampling,” Dr. Seder said. He noted that future research will aim to analyze the data by tumor …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… patients when guidelines and protocols vary and more research is needed. … Recurrence Remains a Risk Even for …

Keynote Address Explores the Future of Biomarkers in the ADC Era

… R. Hirsch outlined the current state of knowledge in ADC research, as well as what still needs to be learned. … Keynote …

Arrhythmias after Radiotherapy—What Do (and Don’t) We Know?

… Researchers examine emerging data demonstrating that …

Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions